|
S100P expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.209610E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.778000E-01 |
| Normal-vs-Stage2 |
2.950400E-01 |
| Normal-vs-Stage3 |
3.350800E-01 |
| Normal-vs-Stage4 |
7.870600E-01 |
| Stage1-vs-Stage2 |
1.703380E-01 |
| Stage1-vs-Stage3 |
1.765210E-01 |
| Stage1-vs-Stage4 |
3.568400E-01 |
| Stage2-vs-Stage3 |
6.438800E-01 |
| Stage2-vs-Stage4 |
3.499600E-01 |
| Stage3-vs-Stage4 |
3.747800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.007600E-01 |
| Normal-vs-AfricanAmerican |
3.132000E-01 |
| Normal-vs-Asian |
3.684200E-01 |
| Caucasian-vs-AfricanAmerican |
2.223600E-01 |
| Caucasian-vs-Asian |
4.034000E-01 |
| AfricanAmerican-vs-Asian |
3.630400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.558400E-01 |
| Normal-vs-Female |
2.730400E-01 |
| Male-vs-Female |
4.273400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.526000E-01 |
| Normal-vs-Extreme_Weight |
2.977400E-01 |
| Normal-vs-Obese |
3.798600E-01 |
| Normal-vs-Extreme_Obese |
3.769600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.045400E-01 |
| Normal_Weight-vs-Obese |
3.115200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.109000E-01 |
| Extreme_Weight-vs-Obese |
1.398580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.583800E-01 |
| Obese-vs-Extreme_Obese |
9.466800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.695600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.205600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.636200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.365800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.512350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.395390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.721800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.323230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.269900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.271640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.087800E-01 |
| Normal-VS-Type2 PRCC |
2.787200E-01 |
| Normal-VS-KIRP CIMP |
4.257600E-01 |
| Normal-VS-Unclassified PRCC |
3.229000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.772400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.436800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.661600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.708450E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.957800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.357200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.777400E-01 |
| Normal-vs-N1 |
3.575800E-01 |
| Normal-vs-N2 |
2.758600E-01 |
| N0-vs-N1 |
3.303600E-01 |
| N0-vs-N2 |
6.119000E-01 |
| N1-vs-N2 |
4.003200E-01 |
|
|
